SALLIE WALKER: Open Payments
NPI 1306889878 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$679 in 34 payments from 20 companies in 2025. Trend: 2023 $1,612 · 2024 $1,195 · 2025 $679
Food & beverage: $679
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| Incyte Corporation | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| SHIELD THERAPEUTICS INC | 1 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Genentech USA, Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Celgene Corporation | 2 | $29 |
Products named: JAKAFI, NINLARO, ACCRUFER, VERZENIO, KEYTRUDA, Enhertu, REBLOZYL, SARCLISA.
Industry payments across OK — which companies pay providers there.
